ORBIMED ADVISORS LLC
SIONORBIMED ADVISORS LLC serves as director, 10 percent owner: at Sionna Therapeutics, Inc. (SION). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.
ORBIMED ADVISORS LLC's Insider Trading at ORIC Pharmaceuticals, Inc. (ORIC)
Buys
0 · $0.00
Sells
3 · $11.88M
Total Shares Bought
0
Total Shares Sold
416,782
ORBIMED ADVISORS LLC's Insider Trading at Janux Therapeutics, Inc. (JANX)
Buys
0 · $0.00
Sells
2 · $3.09M
Total Shares Bought
0
Total Shares Sold
159,800
Showing 51–55 of 55
Related Insiders
Benjamin Hohl
officer: CHIEF FINANCIAL OFFICER
ELVNSell · Aug 19, 2026
Helen Louise Collins
officer: CHIEF MEDICAL OFFICER
ELVNSell · Aug 19, 2026
Erez Chimovits
director, 10 percent owner:
BRVEBuy · Aug 11, 2026
AH Bio Fund IV, L.P.
10 percent owner
BRVEBuy · Aug 11, 2026
David Charles Lubner
director
BRVEBuy · Aug 7, 2026
Michele A. Anderson
officer: Chief Development Officer
BRVEBuy · Aug 7, 2026
Forbion Growth Opportunities Fund III Cooperatief U.A.
10 percent owner
BRVEBuy · Aug 7, 2026
David I Malek
director
BRVEBuy · Aug 7, 2026